Birgit Weynand
- Otorhinolaryngology top 1%
- Head and Neck Cancer Studies 14
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research 16
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 20
- Lung Cancer Treatments and Mutations 16
- Medical Imaging and Pathology Studies 14
- Cancer Research top 5%
- Immunology top 5%
-
- Transplantation: Methods and Outcomes 18
-
- SARS-CoV-2 and COVID-19 Research 16
-
- Neuroendocrine Tumor Research Advances 14
Birgit Weynand
174 papers receiving 4.9k citations
Hit Papers
Peers
Comparison fields: 5 of 141
- Otorhinolaryngology 429
- Oncology 1.6k
- Pulmonary and Respiratory Medicine 1.8k
- Cancer Research 622
- Immunology 735
Countries citing papers authored by Birgit Weynand
This map shows the geographic impact of Birgit Weynand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birgit Weynand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birgit Weynand more than expected).
Fields of papers citing papers by Birgit Weynand
This network shows the impact of papers produced by Birgit Weynand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birgit Weynand. The network helps show where Birgit Weynand may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Birgit Weynand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 11 | |
| 8 | 2022 | 12 | |
| 9 | 2022 | 5 | |
| 10 | 2021 | 1 | |
| 11 | 2021 | 8 | |
| 12 | 2021 | 4 | |
| 13 | 2019 | 30 | |
| 14 | 2019 | 22 | |
| 15 | PD-L1 testing for non-small cell lung cancer : Belgian guidelines | 2018 | 1 |
| 16 | Phenotype molding of stromal cells in the lung tumor microenvironmentbreakdown → | 2018 | 1037 |
| 17 | Pathological diagnosis and molecular testing in non-small cell lung cancer: Belgian guidelines | 2016 | 4 |
| 18 | 2010 | 132 | |
| 19 | Synovial sarcoma of the pleura: report of four cases. | 2002 | 2 |
| 20 | 1998 | 13 |
About Birgit Weynand
Birgit Weynand is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine, Oncology, Surgery and Microbiology, having authored 188 papers that have together received 5.0k indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (20 papers), Transplantation: Methods and Outcomes (18 papers), Pancreatic and Hepatic Oncology Research (16 papers), SARS-CoV-2 and COVID-19 Research (16 papers), Lung Cancer Treatments and Mutations (16 papers), Medical Imaging and Pathology Studies (14 papers), Neuroendocrine Tumor Research Advances (14 papers) and Head and Neck Cancer Studies (14 papers). The work is most often cited by research in Otorhinolaryngology (429 citations), Oncology (1.6k citations), Pulmonary and Respiratory Medicine (1.8k citations), Cancer Research (622 citations) and Immunology (735 citations). Birgit Weynand has collaborated with scholars based in Belgium, United States and France. Frequent co-authors include Marc Hamoir, Max Lonneux, H Reychler, Vincent Grégoire, Thierry Duprez, Erik Verbeken, Jean‐François Daisne, Els Wauters, Herbert Decaluwé and Peter Carmeliet. Their work appears in journals such as Frontiers in Immunology, European Respiratory Journal, CHEST Journal, Lung Cancer and The Journal of Heart and Lung Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.